Publications by authors named "Sin G Kim"

Claim this Profile
O
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial.
Deborah B Horn, Donna H Ryan, Sanja Giljanovic Kis, Breno Alves, Yiming Mu, Sin Gon Kim

Lancet· December 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety in tirzepatide-treated Korean adults with type 2 diabetes-A post hoc analysis of SURPASS-AP-combo and SURPASS-3.
Byung Wan Lee, Chang Beom Lee, Soo Lim, Sin Gon Kim, Nan Hee Kim

Diabetes Obes Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sodium-glucose cotransporter 2 inhibitor ameliorates thiazolidinedione-induced fluid retention through vascular leakage reduction in white adipose tissue.
Ji Yoon Kim, Hye-Min Jang, Hye-Jin Lee, Ah Hyeon Lee, Dong-Hoon Kim, Sin Gon Kim, Nam Hoon Kim

Diabetes Obes Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of pioglitazone versus dapagliflozin as an add-on to metformin and alogliptin combination therapy: the EPIDOTE study.
Kyuho Kim, Seung-Hyun Ko, Jae-Seung Yun, Kwan-Woo Lee, Eun Sook Kim, Jae Hyeon Kim, Sang Yong Kim, Mikyung Kim, Sungrae Kim, Sin Gon Kim, Bo Hyun Kim

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double-blind, multicentre, therapeutic confirmatory phase 3 clinical trial.
Seung-Hwan Lee, Kyung Ah Han, Eun-Gyoung Hong, Jun Goo Kang, Choon Hee Chung, Sin Gon Kim, So Hun Kim, Hae Jin Kim

Diabetes Obes Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Malignancy risk in AUS thyroid lesions: comparison between FNA and CNB with implications for NIFTP diagnosis.
Yeseul Kim, Jae Ho Shin, You-Na Sung, Dawon Park, Harim Oh, Kyeong Jin Kim, Hyun Joo Kim, Sin Gon Kim, Hoon Yub Kim

Front Endocrinol (Lausanne)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-Cell Function, Insulin Sensitivity, and Metabolic Characteristics in Young-Onset Type 2 Diabetes Mellitus: Findings from Anam Diabetes Observational Study.
Ji Yoon Kim, Jiyoon Lee, Sin Gon Kim, Nam Hoon Kim

Diabetes Metab J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fenofibrate therapy and risk of heart failure outcomes in patients with Type 2 diabetes: a propensity-matched cohort study.
Ji Yoon Kim, Nam Hoon Kim, Jiyoon Lee, Dong-Hoon Kim, Sin Gon Kim

Eur Heart J Cardiovasc Pharmacother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Thyroid Cancer-specific Mortality Metrics: a Response to Recent Commentary.
Kyeong Jin Kim, Jimi Choi, Sue K Park, Young Joo Park, Sin Gon Kim

Int J Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignancy risk in AUS thyroid lesions: comparison between FNA and CNB with implications for NIFTP diagnosis.
Yeseul Kim, Jae Ho Shin, You-Na Sung, Dawon Park, Harim Oh, Kyeong Jin Kim, Hyun Joo Kim, Sin Gon Kim, Hoon Yub Kim

Front Endocrinol (Lausanne)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-year oral antidiabetic adherence and long-term complications in newly diagnosed type 2 diabetes.
Nam Hoon Kim, Jun Sung Moon, Kyoung Hwa Ha, Jihyun Kim, Kyoung-Eun Kwon, Sin Gon Kim, Dae Jung Kim

Diabetes Res Clin Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Effectiveness of Pravastatin in Korean Patients with Dyslipidemia Based on the Cardiovascular Risk Classification: Pooled Analysis of Four Observational Studies.
In-Kyung Jeong, Hyuk-Sang Kwon, Dae Jung Kim, Sin Gon Kim

Endocrinol Metab (Seoul)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once‑weekly IcoSema versus once‑weekly insulin icodec in type 2 diabetes management (COMBINE 1): an open‑label, multicentre, treat‑to‑target, randomised, phase 3a trial.
Chantal Mathieu, Francesco Giorgino, Sin Gon Kim, Jonas Hughes Larsen, Athena Philis-Tsimikas

Lancet Diabetes Endocrinol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Reply: Ischemic Stroke, Type 2 Diabetes, Glucose-Lowering Drugs, and Cardiovascular Events.
Jae Hyun Bae, Jimi Choi, Nam Hoon Kim, Sin Gon Kim

Mayo Clin Proc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of parity on the risk of nonalcoholic fatty liver disease defined by hepatic steatosis index: A nationwide cohort study.
So-Hyeon Hong, Soon Young Hwang, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Sin Gon Kim, Nan Hee Kim

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2025 Korean Thyroid Association Management Guidelines for Radioactive Iodine Therapy in Patients with Hyperthyroidism.
Kyeong Jin Kim, Eyun Song, Mijin Kim, Hyemi Kwon, Eu Jeong Ku, Sun Wook Kim, Tae Yong Kim, Sin Gon Kim, Jee Soo Kim

Endocrinol Metab (Seoul)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Muscle Quality on Muscle Strength and Physical Performance Beyond Muscle Mass or Diabetes Status.
Jung A Kim, Chol Shin, Inha Jung, So Young Park, Da Young Lee, Kyoung Jin Kim, Kyeong Jin Kim, Nam Hoon Kim, Sin Gon Kim, Nan Hee Kim

J Cachexia Sarcopenia Muscle· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study Design and Protocol for a Randomized Controlled Trial of Enavogliflozin to Evaluate Cardiorenal Outcomes in Type 2 Diabetes (ENVELOP).
Nam Hoon Kim, Soo Lim, In-Kyung Jeong, Eun-Jung Rhee, Jun Sung Moon, Sang Soo Kim, Sang Yong Kim, Sin Gon Kim

Diabetes Metab J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Phenotyping of Rare Endocrine Diseases Across International Data Networks and the Effect of Granularity of Original Vocabulary.
Seunghyun Lee, Namki Hong, Gyu Seop Kim, Jing Li, Xiaoyu Lin, Kyoung Jin Kim, Sin Gon Kim

Yonsei Med J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Outcomes With Antidiabetic Drugs in People With Type 2 Diabetes and a Prior Stroke.
Jae Hyun Bae, Jimi Choi, Nam Hoon Kim, Sin Gon Kim

Mayo Clin Proc· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling Risk Factors for Treatment Failure in Patients with Graves' Disease: A Nationwide Cohort Study in Korea.
Jung A Kim, Kyeong Jin Kim, Jimi Choi, Kyoung Jin Kim, Eyun Song, Nam Hoon Kim, Nan Hee Kim, Sin Gon Kim

Endocrinol Metab (Seoul)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Income-Related Disparities in Mortality Among Young Adults With Type 2 Diabetes.
Ji Yoon Kim, Sojeong Park, Minae Park, Nam Hoon Kim, Sin Gon Kim

JAMA Netw Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE).
Nam Hoon Kim, Juneyoung Lee, Suk Chon, Jae Myung Yu, In-Kyung Jeong, Won Jun Kim, Kyoung-Ah Kim, Sang Soo Kim, Chong Hwa Kim, Sang-Yong Kim, Jaetaek Kim, Tae Nyun Kim, Hee Kyung Kim, Sin Gon Kim

Endocrinol Metab (Seoul)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Patterns and Preferences for Graves' Disease in Korea: Insights from a Nationwide Cohort Study.
Kyeong Jin Kim, Jimi Choi, Soo Myoung Shin, Jung A Kim, Kyoung Jin Kim, Sin Gon Kim

Endocrinol Metab (Seoul)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis